MoonLake Immunotherapeutics
MoonLake Immunotherapeutics (MLTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MLTX · as of Jun 8, 2026
Key Statistics
Explore MoonLake Immunotherapeutics Data
mltx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 18 · Buy rate: 77.8%
The MLTX analyst consensus is Buy, based on ratings from 18 Wall Street analysts over the past 3 months. The average 12-month price target is $28.50, representing +58.33% upside from the current price of $18.00.
Competitors & Peers
mltx competitorsMLTX
ABSI
AVBP
CTMX
ERAS
MBXStock Performance
Full HistoryAbout MoonLake Immunotherapeutics
MoonLake Immunotherapeutics operates as a clinical-stage biopharmaceutical company, concentrating its efforts on discovering and developing novel therapies. The company's primary focus is the advancem…
what is moonlake immunotherapeutics · mltx stock overview · moonlake immunotherapeutics company profile · who is moonlake immunotherapeutics ceo · mltx NASDAQ · moonlake immunotherapeutics headquarters · moonlake immunotherapeutics business segments
About Stock Overview & Key Data
MoonLake Immunotherapeutics (MLTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 20, 2020. As of the latest trading session, MLTX stock price is $18.00, with a market capitalization of $1.3B. The stock has returned -61.15% over the past 12 months and +37.42% year-to-date.
According to 18 Wall Street analysts, the consensus rating for MoonLake Immunotherapeutics stock is Buy, with an average 12-month price target of $28.50. In fiscal year 2025, MoonLake Immunotherapeutics reported revenue of — and net income of -$227.3M. For detailed data — including MoonLake Immunotherapeutics revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, MoonLake Immunotherapeutics (MLTX) stock price is $18.00. The stock is traded on NASDAQ under the ticker symbol MLTX. The 52-week range is $5.95 – $62.75.